NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1/CXCL8 axis
Article in Cancer Letters (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Cancer Letters (April 2024)
Article in Life Sciences (March 2024)
Article in EXCLI Journal (March 2024)